Search

everythinglearnresearchcommunity

for

Search:↓

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Treat adult facial vascular anomalies with lasers, surgery, or observation, depending on the patient's specific condition.

Hair growth is influenced by factors like genetics and nutrition, and more research is needed to understand hair loss and growth mechanisms.

Acne inversa is an epithelial-driven disease where inflammation is caused by cyst rupture, and treatments should focus on preventing tendril growth for better results.

Derma rollers show promise for skin improvement and drug delivery, but more research is needed on their safety and effectiveness.

There is no standard treatment for the rare Cronkhite–Canada syndrome, which can be fatal and lead to cancer.

Juniperus plants contain compounds with potential for developing various medical treatments.

miR-195-5p reduces hair growth ability in cells by blocking a specific growth signal.

Less AgNOR protein production is linked to hair loss.

Moderately high prolactin levels do not cause hair loss in women.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

Inflammation plays a key role in activating skin stem cells for hair growth and wound healing, but more research is needed to understand how it directs cell behavior.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

Hair follicle stem cells are promising for wound healing but require more research for safe clinical use.

EGFR inhibitors can cause various skin issues during cancer treatment, and managing these is important for patient care.

Local skin glucocorticoid production is crucial for healthy skin, and its disruption can lead to skin diseases.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

Skin problems in older people can indicate hormonal diseases, nutritional deficiencies, or conditions like diabetes, menopause, and HIV.

Estrogen increases blood vessel growth factor production, while testosterone blocks this increase.

Women experience various skin issues at different life stages, requiring careful treatment and awareness.

COVID-19 may harm male fertility and damage the reproductive system.

Stem cells can help regenerate hair follicles.

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

Women with female-pattern baldness produce more testosterone, but 5a-reductase inhibition treatment won't help.

The osteopontin gene is active in a specific part of rat hair follicles during a certain hair growth phase and might affect hair cycle and diseases.

Finasteride effectively treats enlarged prostate and male baldness, improves symptoms of hirsutism in women, but doesn't work for acne, and may delay prostate cancer progression with few side effects.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.